Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
62,912,484
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
31,326,219
-
Shares change
-
+2,442,226
-
Total reported value, excl. options
-
$548,559,268
-
Value change
-
+$40,918,864
-
Put/Call ratio
-
1.39%
-
Number of buys
-
59
-
Number of sells
-
-35
-
Price
-
$17.51
Significant Holders of MACROGENICS INC - COM (MGNX) as of Q2 2017
125 filings reported holding MGNX - MACROGENICS INC - COM as of Q2 2017.
MACROGENICS INC - COM (MGNX) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31,326,219 shares
of 62,912,484 outstanding shares and own 49.79% of the company stock.
Largest 10 shareholders include FMR LLC (5,238,917 shares), OppenheimerFunds, Inc. (3,582,862 shares), BlackRock Inc. (2,602,987 shares), BB BIOTECH AG (2,350,112 shares), Boxer Capital, LLC (2,115,000 shares), VANGUARD GROUP INC (1,391,322 shares), Point72 Asset Management, L.P. (1,084,417 shares), InterWest Venture Management Co (1,074,316 shares), WASATCH ADVISORS INC (1,044,243 shares), and STATE STREET CORP (969,221 shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.